JNJ stock research
Johnson & Johnson stock analysis and valuation
Johnson & Johnson combines innovative medicines with medical technology. Research should separate the growth, margin and risk profiles of these operations while accounting for pipeline investment and legal liabilities.
Johnson & Johnson
JNJ
$266.64
Market Cap
$641.89B
Volume
N/A
Company Info
Healthcare
Drug Manufacturers - General
About
Business summary is not available yet for this company.
Employees
—
Not reported
Website
—
Opens in a new tab
Showing the saved market snapshot from 2026-10-26 14:55 UTC while live data refreshes.
What to examine in Johnson & Johnson
- Pharmaceutical product growth and pipeline
- Medical technology demand and margins
- Litigation, cash flow and capital allocation
Risks to include
- Patent expirations and clinical setbacks
- Product liability and litigation
- Healthcare pricing pressure
Useful models for Johnson & Johnson
No single model captures every business. Use these methods as complementary viewpoints and test the assumptions behind each result.
Related stock analysis
Compare Johnson & Johnson with other curated companies in the Healthcare sector.